211 related articles for article (PubMed ID: 27294805)
1. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.
Yao J; Hu LL; Li XM; Shan K; Zhou RM; Ge HM; Yao MD; Jiang Q; Zhao C; Yan B
Biomed Pharmacother; 2019 Mar; 111():548-554. PubMed ID: 30597308
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes.
Asato R; Yoshida S; Ogura A; Nakama T; Ishikawa K; Nakao S; Sassa Y; Enaida H; Oshima Y; Ikeo K; Gojobori T; Kono T; Ishibashi T
PLoS One; 2013; 8(1):e54191. PubMed ID: 23372684
[TBL] [Abstract][Full Text] [Related]
5. Epithelial membrane protein-2 (EMP2) and experimental proliferative vitreoretinopathy (PVR).
Telander DG; Morales SA; Mareninov S; Forward K; Gordon LK
Curr Eye Res; 2011 Jun; 36(6):546-52. PubMed ID: 21591864
[TBL] [Abstract][Full Text] [Related]
6. P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.
Schiff L; Boles NC; Fernandes M; Nachmani B; Gentile R; Blenkinsop TA
Commun Biol; 2019; 2():162. PubMed ID: 31069271
[TBL] [Abstract][Full Text] [Related]
7. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
9. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy.
Amarnani D; Machuca-Parra AI; Wong LL; Marko CK; Stefater JA; Stryjewski TP; Eliott D; Arboleda-Velasquez JF; Kim LA
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3940-3949. PubMed ID: 28777835
[TBL] [Abstract][Full Text] [Related]
10. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
12. Role of Caveolin-1 for Blocking the Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy.
Nagasaka Y; Kaneko H; Ye F; Kachi S; Asami T; Kato S; Takayama K; Hwang SJ; Kataoka K; Shimizu H; Iwase T; Funahashi Y; Higuchi A; Senga T; Terasaki H
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):221-229. PubMed ID: 28114583
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
14. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy.
Laich Y; Wolf J; Hajdu RI; Schlecht A; Bucher F; Pauleikhoff L; Busch M; Martin G; Faatz H; Killmer S; Bengsch B; Stahl A; Lommatzsch A; Schlunck G; Agostini H; Boneva S; Lange C
Invest Ophthalmol Vis Sci; 2022 May; 63(5):17. PubMed ID: 35579905
[TBL] [Abstract][Full Text] [Related]
16. Proteomic evidence that ABCA4 is vital for traumatic proliferative vitreoretinopathy formation and development.
Wang M; Li Q; Dong H
Exp Eye Res; 2019 Apr; 181():232-239. PubMed ID: 30738069
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy.
He S; Barron E; Ishikawa K; Nazari Khanamiri H; Spee C; Zhou P; Kase S; Wang Z; Dustin LD; Hinton DR
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5579-89. PubMed ID: 26305530
[TBL] [Abstract][Full Text] [Related]
19. [Periostin in the Pathogenesis of Proliferative Vitreoretinopathy].
Ishikawa K
Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):772-80. PubMed ID: 26685481
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
